Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Teva Pharmaceutical Industries - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TEVA
New York
2834
https://www.tevapharm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Teva Pharmaceutical Industries
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
- May 17th, 2024 3:00 pm
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
- May 15th, 2024 12:15 pm
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
- May 14th, 2024 1:40 pm
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
- May 14th, 2024 11:00 am
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
- May 13th, 2024 1:40 pm
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
- May 9th, 2024 4:14 pm
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
- May 9th, 2024 3:37 pm
Affirm stock sinking, Good Buy or Goodbye: Market Domination
- May 9th, 2024 1:33 pm
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
- May 9th, 2024 12:21 pm
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
- May 9th, 2024 10:22 am
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
- May 8th, 2024 8:02 pm
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
- May 8th, 2024 6:10 pm
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
- May 8th, 2024 6:00 pm
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- May 8th, 2024 1:30 pm
REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises
- May 8th, 2024 11:55 am
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
- May 8th, 2024 11:20 am
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
- May 8th, 2024 11:00 am
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
- May 8th, 2024 10:30 am
20 States with the Highest Fertility Rates in the US
- May 7th, 2024 4:45 pm
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
- May 6th, 2024 2:40 pm
Scroll